EV-302 Patient-Reported Outcomes

Shilpa Gupta, MD, shares her findings on patient-reported outcomes from the EV-302 clinical trial with Amanda Nizam, MD. Drs. Gupta and Nizam discuss the unique aspects of the trial, highlighting the impact of enfortumab vedotin and pembrolizumab on progression-free survival and overall survival in metastatic urothelial carcinoma. Get the latest updates and insights on advanced urothelial carcinoma at https://guoncologynow.com/page/advanc....